Overview
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things ("brain fog") and fatigue.
Researchers will compare NE3107 to a placebo (a look-alike substance that contains no drug) to see if NE3107 works to treat neurocognitive and fatigue symptoms of long COVID.
Participants will:
* Take NE3107 or a placebo twice daily for 84 days
* Visit the clinic 5 times for checkups and tests and have a follow up phone call
Principal investigator
Eligibility criteria
* 18 years to 64 years of age
* diagnosed with Long COVID with symptoms of fatigue and brain fog for at least 3 months
* agree to use birth control measures
* provide voluntary consent
* willing to allow blood collection
* pass all screening tests and procedures
Exclusion Criteria:
* has received a COVID-19 vaccination within 30 days
* previous admission to the intensive care unit for COVID-19
* medical history of major mental or physical illness prior to COVID-19 infection
Participate in this trial
Are you interested in enrolling in this study? Learn more here.
I'm Interested In ParticipatingFor Referring Providers
Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.